{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:02:33Z","timestamp":1790668953780,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T00:00:00Z","timestamp":1465862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/npp.2016.91","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T11:09:56Z","timestamp":1465902596000},"page":"2772-2781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-9878","authenticated-orcid":false,"given":"Gianluigi","family":"Tanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Hiranita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C","family":"Quarterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Coggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"key":"BFnpp201691_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.2174\/1871527314666150529132503","volume":"14","author":"R Bachtell","year":"2015","unstructured":"Bachtell R, Hutchinson MR, Wang X, Rice KC, Maier SF, Watkins LR (2015). Targeting the Toll of drug abuse: the translational potential of Toll-like receptor 4. CNS Neurol Disord Drug Targets 14: 692\u2013699.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"BFnpp201691_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbi.2013.08.006","volume":"34","author":"LA Campbell","year":"2013","unstructured":"Campbell LA, Avdoshina V, Rozzi S, Mocchetti I (2013). CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal. Brain Behav Immun 34: 130\u2013140.","journal-title":"Brain Behav Immun"},{"key":"BFnpp201691_CR3","first-page":"65","volume":"59","author":"G Di Chiara","year":"1993","unstructured":"Di Chiara G, Acquas E, Tanda G, Cadoni C (1993). Drugs of abuse: biochemical surrogates of specific aspects of natural reward? Biochem Soc Symp 59: 65\u201381.","journal-title":"Biochem Soc Symp"},{"key":"BFnpp201691_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-6147(92)90062-B","volume":"13","author":"G Di Chiara","year":"1992","unstructured":"Di Chiara G, North RA (1992). Neurobiology of opiate abuse. Trends Pharmacol Sci 13: 185\u2013193.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp201691_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1749-6632.1999.tb09283.x","volume":"877","author":"G Di Chiara","year":"1999","unstructured":"Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S et al (1999). Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell\/extended amygdala dopamine. Ann N Y Acad Sci 877: 461\u2013485.","journal-title":"Ann N Y Acad Sci"},{"key":"BFnpp201691_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1054-3589(08)60911-4","volume":"42","author":"G Di Chiara","year":"1998","unstructured":"Di Chiara G, Tanda G, Cadoni C, Acquas E, Bassareo V, Carboni E (1998). Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. Adv Pharmacol 42: 983\u2013987.","journal-title":"Adv Pharmacol"},{"key":"BFnpp201691_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00008877-199611000-00009","volume":"7","author":"G Di Chiara","year":"1996","unstructured":"Di Chiara G, Tanda G, Carboni E (1996). Estimation of in vivo neurotransmitter release by brain microdialysis: the issue of validity. Behav Pharmacol 7: 640\u2013657.","journal-title":"Behav Pharmacol"},{"key":"BFnpp201691_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0014-2999(78)90369-2","volume":"47","author":"R Dingledine","year":"1978","unstructured":"Dingledine R, Iversen LL, Breuker E (1978). Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol 47: 19\u201327.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201691_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nn.3295","volume":"16","author":"F Ferrini","year":"2013","unstructured":"Ferrini F, Trang T, Mattioli TA, Laffray S, Del'Guidice T, Lorenzo LE et al (2013). Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl(-) homeostasis. Nat Neurosci 16: 183\u2013192.","journal-title":"Nat Neurosci"},{"key":"BFnpp201691_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00540-012-1469-4","volume":"27","author":"H Fukagawa","year":"2013","unstructured":"Fukagawa H, Koyama T, Kakuyama M, Fukuda K (2013). Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4. J Anesth 27: 93\u201397.","journal-title":"J Anesth"},{"key":"BFnpp201691_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biopsych.2010.07.026","volume":"69","author":"L Garces-Ramirez","year":"2011","unstructured":"Garces-Ramirez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM et al (2011). Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry 69: 208\u2013217.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201691_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.neuroscience.2010.02.011","volume":"167","author":"MR Hutchinson","year":"2010","unstructured":"Hutchinson MR, Lewis SS, Coats BD, Rezvani N, Zhang Y, Wieseler JL et al (2010). Possible involvement of toll-like receptor 4\/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience 167: 880\u2013893.","journal-title":"Neuroscience"},{"key":"BFnpp201691_CR13","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","volume":"32","author":"MR Hutchinson","year":"2012","unstructured":"Hutchinson MR, Northcutt AL, Hiranita T, Wang X, Lewis SS, Thomas J et al (2012). Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci 32: 11187\u201311200.","journal-title":"J Neurosci"},{"key":"BFnpp201691_CR14","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1124\/pr.110.004135","volume":"63","author":"MR Hutchinson","year":"2011","unstructured":"Hutchinson MR, Shavit Y, Grace PM, Rice KC, Maier SF, Watkins LR (2011). Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev 63: 772\u2013810.","journal-title":"Pharmacol Rev"},{"key":"BFnpp201691_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.05.039","volume":"76 Pt B","author":"MR Hutchinson","year":"2014","unstructured":"Hutchinson MR, Watkins LR (2014). Why is neuroimmunopharmacology crucial for the future of addiction research? Neuropharmacology 76 Pt B: 218\u2013227.","journal-title":"Neuropharmacology"},{"key":"BFnpp201691_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","volume":"28","author":"MR Hutchinson","year":"2008","unstructured":"Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW et al (2008). Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 28: 20\u201329.","journal-title":"Eur J Neurosci"},{"key":"BFnpp201691_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1021\/jm00202a018","volume":"21","author":"I Iijima","year":"1978","unstructured":"Iijima I, Minamikawa J, Jacobson AE, Brossi A, Rice KC (1978). Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. J Med Chem 21: 398\u2013400.","journal-title":"J Med Chem"},{"key":"BFnpp201691_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483\u2013488.","journal-title":"J Neurosci"},{"key":"BFnpp201691_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217\u2013238.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201691_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nri3151","volume":"12","author":"CC Lee","year":"2012","unstructured":"Lee CC, Avalos AM, Ploegh HL (2012). Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 12: 168\u2013179.","journal-title":"Nat Rev Immunol"},{"key":"BFnpp201691_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jpain.2012.02.005","volume":"13","author":"SS Lewis","year":"2012","unstructured":"Lewis SS, Loram LC, Hutchinson MR, Li CM, Zhang Y, Maier SF et al (2012). (+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. J Pain 13: 498\u2013506.","journal-title":"J Pain"},{"key":"BFnpp201691_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1213\/00000539-199310000-00020","volume":"77","author":"LL Lockwood","year":"1993","unstructured":"Lockwood LL, Silbert LH, Laudenslager ML, Watkins LR, Maier SF (1993). Anesthesia-induced modulation of in vivo antibody levels: a study of pentobarbital, chloral hydrate, methoxyflurane, halothane, and ketamine\/xylazine. Anesth Analg 77: 769\u2013774.","journal-title":"Anesth Analg"},{"key":"BFnpp201691_CR23","doi-asserted-by":"publisher","first-page":"e97361","DOI":"10.1371\/journal.pone.0097361","volume":"9","author":"TA Mattioli","year":"2014","unstructured":"Mattioli TA, Leduc-Pessah H, Skelhorne-Gross G, Nicol CJ, Milne B, Trang T et al (2014). Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence. PLoS One 9: e97361.","journal-title":"PLoS One"},{"key":"BFnpp201691_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/00000542-199706000-00018","volume":"86","author":"H Miyazaki","year":"1997","unstructured":"Miyazaki H, Nakamura Y, Arai T, Kataoka K (1997). Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology 86: 1359\u20131366.","journal-title":"Anesthesiology"},{"key":"BFnpp201691_CR25","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/mp.2014.177","volume":"20","author":"AL Northcutt","year":"2015","unstructured":"Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA et al (2015). DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Mol Psychiatry 20: 1525\u20131537.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201691_CR26","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates IV edn. Academic Press: Sydney, Australia."},{"key":"BFnpp201691_CR27","doi-asserted-by":"publisher","first-page":"12304","DOI":"10.1073\/pnas.92.26.12304","volume":"92","author":"FE Pontieri","year":"1995","unstructured":"Pontieri FE, Tanda G, Di Chiara G (1995). Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the \u2018shell\u2019 as compared with the \u2018core\u2019 of the rat nucleus accumbens. Proc Natl Acad Sci USA 92: 12304\u201312308.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201691_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/382255a0","volume":"382","author":"FE Pontieri","year":"1996","unstructured":"Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255\u2013257.","journal-title":"Nature"},{"key":"BFnpp201691_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1006\/bbrc.1998.8415","volume":"245","author":"S Roy","year":"1998","unstructured":"Roy S, Cain KJ, Chapin RB, Charboneau RG, Barke RA (1998). Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun 245: 392\u2013396.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFnpp201691_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tips.2014.06.008","volume":"35","author":"P Skolnick","year":"2014","unstructured":"Skolnick P, Davis H, Arnelle D, Deaver D (2014). Translational potential of naloxone and naltrexone as TLR4 antagonists. Trends Pharmacol Sci 35: 431\u2013432.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp201691_CR31","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/bph.12028","volume":"168","author":"CW Stevens","year":"2013","unstructured":"Stevens CW, Aravind S, Das S, Davis RL (2013). Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. Br J Pharmacol 168: 1421\u20131429.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201691_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1124\/jpet.104.080465","volume":"313","author":"G Tanda","year":"2005","unstructured":"Tanda G, Ebbs A, Newman AH, Katz JL (2005). Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine. J Pharmacol Exp Ther 313: 613\u2013620.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201691_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/jpet.106.118067","volume":"321","author":"G Tanda","year":"2007","unstructured":"Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH et al (2007). Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321: 334\u2013344.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201691_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1471-4159.2008.05361.x","volume":"106","author":"G Tanda","year":"2008","unstructured":"Tanda G, Kopajtic TA, Katz JL (2008). Cocaine-like neurochemical effects of antihistaminic medications. J Neurochem 106: 147\u2013157.","journal-title":"J Neurochem"},{"key":"BFnpp201691_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1124\/jpet.109.154302","volume":"330","author":"G Tanda","year":"2009","unstructured":"Tanda G, Newman AH, Ebbs AL, Tronci V, Green JL, Tallarida RJ et al (2009). Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. J Pharmacol Exp Ther 330: 802\u2013809.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201691_CR36","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","volume":"276","author":"G Tanda","year":"1997","unstructured":"Tanda G, Pontieri FE, Di Chiara G (1997a). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276: 2048\u20132050.","journal-title":"Science"},{"key":"BFnpp201691_CR37","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/j.1460-9568.1997.tb01375.x","volume":"9","author":"G Tanda","year":"1997","unstructured":"Tanda G, Pontieri FE, Frau R, Di Chiara G (1997b). Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9: 2077\u20132085.","journal-title":"Eur J Neurosci"},{"key":"BFnpp201691_CR38","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/npp.2015.221","volume":"41","author":"AM Taylor","year":"2016","unstructured":"Taylor AM, Castonguay A, Ghogha A, Vayssiere P, Pradhan AA, Xue L et al (2016). Neuroimmune regulation of GABAergic neurons within the ventral tegmental area during withdrawal from chronic morphine. Neuropsychopharmacology 41: 949\u2013959.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201691_CR39","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1523\/JNEUROSCI.4036-14.2015","volume":"35","author":"AM Taylor","year":"2015","unstructured":"Taylor AM, Castonguay A, Taylor AJ, Murphy NP, Ghogha A, Cook C et al (2015). Microglia disrupt mesolimbic reward circuitry in chronic pain. J Neurosci 35: 8442\u20138450.","journal-title":"J Neurosci"},{"key":"BFnpp201691_CR40","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopsych.2012.12.019","volume":"73","author":"FR Theberge","year":"2013","unstructured":"Theberge FR, Li X, Kambhampati S, Pickens CL St, Laurent R, Bossert JM et al (2013). Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol Psychiatry 73: 729\u2013737.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201691_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/bph.13394","volume":"173","author":"X Wang","year":"2016","unstructured":"Wang X, Zhang Y, Peng Y, Hutchinson MR, Rice KC, Yin H et al (2016). Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br J Pharmacol 173: 856\u2013869.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201691_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","volume":"30","author":"LR Watkins","year":"2009","unstructured":"Watkins LR, Hutchinson MR, Rice KC, Maier SF (2009). The \u2018toll\u2019 of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 30: 581\u2013591.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp201691_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0376-8716(98)00063-5","volume":"51","author":"RA Wise","year":"1998","unstructured":"Wise RA (1998). Drug-activation of brain reward pathways. Drug Alcohol Depend 51: 13\u201322.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201691_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.taap.2007.11.027","volume":"228","author":"GJ Wu","year":"2008","unstructured":"Wu GJ, Chen TL, Ueng YF, Chen RM (2008). Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 228: 105\u2013113.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFnpp201691_CR45","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12031-014-0373-9","volume":"54","author":"HF Xiang","year":"2014","unstructured":"Xiang HF, Cao DH, Yang YQ, Wang HQ, Zhu LJ, Ruan BH et al (2014). Isoflurane protects against injury caused by deprivation of oxygen and glucose in microglia through regulation of the Toll-like receptor 4 pathway. J Mol Neurosci 54: 664\u2013670.","journal-title":"J Mol Neurosci"},{"key":"BFnpp201691_CR46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3892\/mmr.2015.3408","volume":"12","author":"Z Xiao","year":"2015","unstructured":"Xiao Z, Ren P, Chao Y, Wang Q, Kuai J, Lv M et al (2015). Protective role of isoflurane pretreatment in rats with focal cerebral ischemia and the underlying molecular mechanism. Mol Med Rep 12: 675\u2013683.","journal-title":"Mol Med Rep"},{"key":"BFnpp201691_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2010.11.063","volume":"489","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Li H, Li Y, Sun X, Zhu M, Hanley G et al (2011). Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice. Neurosci Lett 489: 43\u201347.","journal-title":"Neurosci Lett"},{"key":"BFnpp201691_CR48","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1213\/ANE.0b013e318230b3fd","volume":"113","author":"YL Zhao","year":"2011","unstructured":"Zhao YL, Xiang Q, Shi QY, Li SY, Tan L, Wang JT et al (2011). GABAergic excitotoxicity injury of the immature hippocampal pyramidal neurons' exposure to isoflurane. Anesth Analg 113: 1152\u20131160.","journal-title":"Anesth Analg"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201691.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201691","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201691.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:57:22Z","timestamp":1684454242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnpp201691"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.91","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]},"assertion":[{"value":"21 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}